TSPO and major depressive disorder: In a 18F-FEPPA PET study in MDD patients investigating microglial activation, as measured by translocator protein (TSPO) total distribution volume (VT) throughout grey-matter regions, greater levels of microglial activation were associated with greater duration of untreated MDD.